Nachrichten zur Pfizer Inc. Aktie

Better Beaten-Down Stock to Buy: Pfizer Vs. Moderna

In 2020, many companies tried to develop effective coronavirus vaccines, but two ended up succeeding and dominating the field: Pfizer…

Pfizer (PFE) Increases Yet Falls Behind Market: What Investors Need to Know

In the closing of the recent trading day, Pfizer (PFE) stood at $24.70, denoting a +0.65% change from the preceding…

PFE Secures EU Nod for Expanded Use of RSV Vaccine Abrysvo

The latest decision makes Pfizers Abrysvo the first RSV vaccine approved for use in non-pregnant adults under 50 years of…

Why Major Pharmaceutical Stocks Tumbled on Tuesday

Many investor eyes were on the pharmaceutical industry on Tuesday, and not necessarily for the right reasons. The Trump administrations…

Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?

Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

3 Ultra-High-Yield Dividend Stocks to Buy in April

March winds bring April showers. And April showers bring... a great opportunity to buy ultra-high-yield dividend stocks. I suppose they…

Why I Just Bought These 3 Ultra-High-Yield Dividend Stocks

When a commercial aircraft encounters turbulence, a flight attendant will tell all passengers to return to their seats and buckle…

Pfizer: Value Play or Past Its Prime?

Explore the exciting world of Pfizer (NYSE: PFE) with our expert analysts in this Motley Fool Scoreboard episode. Check out…

Why Pfizer Is My Largest Healthcare Position

Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment toward the…

Heres Why Pfizer (PFE) Fell More Than Broader Market

In the latest trading session, Pfizer (PFE) closed at $25.21, marking a -1.33% move from the previous day.…

US prosecutors probe tip about timing of Pfizer’s COVID vaccine, WSJ reports By Reuters

US prosecutors probe tip about timing of Pfizer’s COVID vaccine, WSJ reports…

Pfizer shares dip amid U.S. vaccine probe reports By Investing.com

Pfizer shares dip amid U.S. vaccine probe reports…

Nasdaq Correction: Was It a Mistake to Add Nvidia, Amazon, and Salesforce to The Dow Jones Industrial Average?

The Dow Jones Industrial Average (DJINDICES: ^DJI) has changed a lot in recent years. In 2020, Salesforce, Amgen, and Honeywell…

5 Large Drug Stocks to Watch as Industry Recovers

R&D innovation is likely to remain a major focus area in 2025. In the Large-Cap Pharmaceuticals industry, AbbVie (ABBV), Novo…

China’s vice premier reassures Apple, Pfizer, Cargill, others of business potential By Reuters

China’s vice premier reassures Apple, Pfizer, Cargill, others of business potential…

Chinas vice premier reassures Apple, Pfizer, Cargill, others of business potential

Chinas Vice Premier He Lifeng sought to reassure foreign corporate chiefs of the countrys business potential when he met with…

Pfizer Is a Dirt-Cheap High-Yield Stock, But Is It a Buy?

Pfizers stock has recently struggled but remains a bargain with generous dividends. Is now a good time to invest in…

Pfizer: Bulls Need To Check Out Its Graham P/E

…

Pharma Stock Roundup: PFEs Final Haleon Stake Sale, AZN, SNY M&A Deals

Pfizer sells 7.3% remaining stake in Haleon. FDA approves the expanded use of JNJ and NVS drugs.…

3 Reasons Pfizer Stock Could Be a Steal of a Deal in 2025

If youre looking for reasonably priced stocks to pick up right now, you shouldnt overlook Pfizer (NYSE: PFE). The pharmaceutical…

2 High-Yield Dividend Stocks That Are Bargain Buys Right Now

Healthcare is a defensive sector that is more resilient to economic downturns than most others. Thats one of several reasons…

Pfizer (PFE) Stock Dips While Market Gains: Key Facts

Pfizer (PFE) closed at $26.21 in the latest trading session, marking a -0.38% move from the prior day.…

This Unstoppable Biotech Stock Just Became an Even Better Buy

Last year, Summit Therapeutics (NASDAQ: SMMT) was one of the stars of the biotech industry. The companys shares soared following…

3 Dividend Stocks to Buy for Reliable Passive Income

Youll need passive income to live well in retirement, especially with Social Securitys uncertain future. The Office of Retirement and…

Pfizer sells entire Haleon stake for $3.24 billion By Investing.com

Pfizer sells entire Haleon stake for $3.24 billion…

Pfizer sells entire Haleon stake for $3.24 billion

Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors and…

Haleon buys £170m of shares as Pfizer offloads final stake

Haleon PLC (LSE:HLN, NYSE:HLN) has bought roughly £170 million of its shares back from former parent company Pfizer Inc (NYSE:PFE, ETR:PFE).   The…

Pfizer to dispose of entire Haleon stake

Haleon shareholder Pfizer will dispose of its entire 7.3% stake in the British consumer healthcare group, a bookrunner said on…

Pfizer Aktie: Entscheidung über Danuglipron-Studie naht

New York (www.aktiencheck.de) - Pfizer-Aktienanalyse von J.P. Morgan Securities: Rating und Kursziel JPMorgan bleibt vorsichtig in Bezug auf Pfizer Inc. (ISIN: US7170811035,…

5 Reasons the Schwab U.S. Dividend Equity ETF Is a Long-Term Buy for 2030 and Beyond

Lets say you have some money in your pocket you want to invest, but youre not sure where to put…

The Smartest Dividend Stocks to Buy With $150 Right Now

Anytime is a great time to invest in stocks. The catch is that you must choose the right stocks. The current…

2 Beaten-Down Stocks Near Their 52-Week Lows That Arent Worth Buying

Buying stocks after they have lost significant market value can lead to excellent returns in the long run, but only…

Down 93%, Is It Finally Time to Buy Moderna?

As we near the five-year anniversary of the COVID-19 pandemic, its a good time to revisit the drugmaker stock that…

The Zacks Analyst Blog Highlights Novo Nordisk, Roche, Pfizer, Arvinas and J&J

Novo Nordisk, Roche, Pfizer, Arvinas and J&J are part of the Zacks top Analyst Blog.…

Pfizer (PFE) Stock Moves -0.43%: What You Should Know

The latest trading day saw Pfizer (PFE) settling at $25.60, representing a -0.43% change from its previous close.…

The State of Weight Loss Drugs

In this podcast, Motley Fool analyst Karl Thiel joins host Ricky Mulvey to check in on the GLP-1 landscape. They…

Pfizer Stock Up Almost 6% in 3 Months: Time to Buy, Sell or Hold?

Investors may stay invested in PFE stock to see how its new growth drivers perform.…

3 ETFs to Buy Now for Passive Dividend Income

With volatility spiking and stock market indexes like the S&P 500 (SNPINDEX: ^GSPC) and Nasdaq Composite (NASDAQINDEX: ^IXIC) down on…

Is Pfizer Inc. (PFE) The Best Cheap Dividend Stock To Buy Right Now?

We recently published a list of 13 Best Cheap Dividend Stocks To Buy Right Now. In this article, we are…

3 Top Dividend Stocks to Buy in March

Investing in dividend stocks can be a great strategy, especially if you pick solid companies that pay reliable and high-yield…

ANALYSE-FLASH: JPMorgan belässt Pfizer auf 'Neutral' - Ziel 30 Dollar

NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Pfizer nach Zahlen…

Pfizer übertrifft Umsatzerwartung - Aktie gefragt

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer hat nach einem überraschend starken Schlussquartal 2024 seinen…

Pfizer peilt für 2025 Umsatz auf Vorjahreshöhe an - Gewinnsteigerung möglich

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer blickt verhalten auf das kommende Jahr. 2025 werde…

Prozess um von der Leyens SMS mit Pfizer geht in heiße Phase

LUXEMBURG (dpa-AFX) - Der Prozess um SMS zwischen EU-Kommissionspräsidentin Ursula von der Leyen und dem Chef…

Pfizer erhöht erneut Prognose - Aktie vorbörslich im Plus

NEW YORK (dpa-AFX) - Beim US-Pharmakonzern Pfizer geht es weiter aufwärts. Nach einem abermals unerwartet…

ANALYSE-FLASH: JPMorgan belässt Pfizer auf 'Neutral' - Ziel 30 Dollar

NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Pfizer mit einem…

Pfizer will bis Ende 2027 rund 1,5 Milliarden US-Dollar einsparen

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer will bis Ende 2027 rund 1,5 Milliarden US-Dollar…

WDH/ANALYSE-FLASH: Jefferies belässt Pfizer auf 'Buy' - Ziel 32 Dollar

(Wiederholung vom Vorabend) NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat die…

ANALYSE-FLASH: JPMorgan belässt Pfizer auf 'Neutral' - Ziel 30 Dollar

NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Pfizer nach Zahlen…

ANALYSE-FLASH: Jefferies senkt Ziel für Pfizer auf 32 Dollar - 'Buy'

NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat das Kursziel für Pfizer nach Zielvorgaben…